Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > irrational exuberance
View:
Post by Carlos66 on Nov 02, 2015 11:14am

irrational exuberance

let's not get too far ahead of ourselves regarding CXR's future.

A guest from CIBC had a list of companies whose business model is growth by acquisiton ranked by a different set of metrics & he mentioned that going forward there will be more scrutiny of acquisitions etc.. That will slow down growth  for all regardless of the sector they are in with only those that are not over-leveraged & in debt.

That being said it seems that the Citron analyst Left has backtracked from his inflammatory statement on Friday that the end of the world is coming to VRX probably according to a side comment from Amber Kanwar, his lawyers told him to dial the rhetoric back a bit. Now he says that this will be his last comment on VRX & that he will be moving on to other targets. I wonder which other Cdn. companies he will focus on next.

Hopefully with more & more companies (banks, MMs) coming out with new & higher price targets now that the rush to judgment/rhetoric is waning & a return to sound/sane economic/financial investment advice.

The company should continue to expound the difference between VRX & CXR's business model & come out with frequent NR about what & with whom they are doing business, because as I said above more scrutiny by all those who give financial advice including gov't regulators/PBMs who will scrutinize prices they have to pay.

An unintended consequence...IMO... might be orphan drug status pricing. Not related

I suspect CXR recovery might be slower than expected not unlike the oil sector earlier expectations of an oil price recovery... lower for longer now.
1st we must get above $60. (maybe by yearend) & then we can talk about $100. & more; so talking about targets above $100. now are more talking your book than anything else.

carlos
Comment by sunshine7 on Nov 02, 2015 11:28am
Rational thinking, however, I do not think there is a parallel to oil and gas stocks. O&G tanked on fundamentals. CXR tanked on market segment sentiment. O&G not returning anytime soon. CXR looking to good gains as sentiment moves up. Agree that it will take longer than some here think.
Comment by adamchess on Nov 02, 2015 11:29am
carlos: It takes less than 5 minutes to determine that Concordia's business model is excellent in the short and long-term and their cashflow easily covers their interest and debt requirements for all time periods. With excess cashflows they can either pay off debt quickly and/or make further investments in product to improve the business even further. A no-brainer at these prices.
Comment by healthstock1234 on Nov 02, 2015 11:41am
The big acquisition is done, we are under low target price estimate $60 CAD on TSX , with Strong Buy Current Target Price High Target Price Estimate 145.00 Low Target Price Estimate  ...more  
Comment by cg16 on Nov 02, 2015 11:43am
The more I learn about CXR the better it gets in my mind. Mark was reminding us on Friday (BNN) that Amco is not a normal acquisition for CXR. The strategy of CXR is actually to just buy drugs, not companies. what he was trying to get investors to understand is that CXR is now perfectly organized to keep with that original strategy of just buying drugs. The Amco deal gives them a worldwide ...more  
Comment by ruben12345 on Nov 02, 2015 11:47am
i take your view that it takes a while and not a one week jump to $80. However, your other comparisons and neglect of fundamentals is not correct
Comment by adamchess on Nov 02, 2015 11:49am
I don't know how you can compare anything about Concordia (CXR) or any healthcares to recovery in the oil & gas sector which are all losing money hand over fist because costs exceed revenues. Once the price improves they will recover. Concord's price now is no reflection of its profitability as nothing has changed. It is very profitable and justified its previous stock prices before ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities